Table 1.

List of Cancers Producing β-hCG in Study

Patients Cancer Type	Total hCG (mIU/mL)	Intact hCG (mIU/mL)
Anaplastic Astrocytoma	17.7	<0.5
Breast Mixed Ductal/Lobular Carcinoma	13.5	0.7
Cervical Adenocarcinoma	11.1	<0.5
Cervical Squamous Cell Carcinoma	40.3	<0.5
Cholangiocarcinoma	12.5	<0.5
Cholangiocarcinoma	11.4	<0.5
Colonic Adenocarcinoma	25.4	1.2
Colonic Adenocarcinoma	757.5	2.7
Colonic Adenocarcinoma	102.8	<0.5
Gastric Adenocarcinoma	37.3	5.5
Lung Squamous Cell Carcinoma	7.6	<0.5
Pancreatic Adenocarcinoma	77.4	0.6
Pancreatic Adenocarcinoma	35.4	2.7
Pancreatic Adenocarcinoma	77.3	<0.5
Pancreatic Adenocarcinoma	16.2	<0.5
Sacral Giant Cell Tumor	48.5	<0.5
Thyroid Medullary Carcinoma	124.9	<0.5

A variety of non-trophoblastic tumors (N=17) were shown to produce β-hCG with comparatively smaller to immeasurable amounts of intact hCG.